Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 37, 2026)
Company announcement No. 48 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 37, 2026) Copenhagen, Denmark, September 14, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Gland Pharma to acquire 100% stake in Gland Pharma USA
The Board of Directors of Gland Pharma has approved the acquisition of 100 per cent of the equity share capital of Gland Pharma USA Inc. a wholly-owned step-down subsidiary of the Company, from Gland Pharma International Pte. Ltd, a wholly-owned…
Aurobindo Pharma gets USFDA approval for generic inhalation aerosol for asthma patients
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol, a generic equivalent of Qvar Inhalation Aerosol marketed by Teva Branded…
Piramal Pharma Morpeth facility gets 7 US FDA observations
Piramal Pharma Limited's Morpeth facility in the UK has received seven observations after an inspection by the US Food and Drug Administration (US FDA), according to a regulatory filing. The US FDA conducted the inspection at the facility from…
Lupin's Strategic Shift: Biosimilars to Drive Future Growth & Global Expansion
Pharma giant Lupin is strategically expanding its biosimilar portfolio and global market presence, targeting a significant $500 million turnover from this segment within the next five years, alongside investments in manufacturing and a flexible…
Tighter scrutiny of Hong Kong IPOs could slow deal flow, analysts say
Securities regulators in Hong Kong and mainland China are doubling down on efforts to raise the quality of Hong Kong initial public offerings (IPOs), which could slow the flow of new listings but would not reduce underlying demand, according to…
AI is hardly the first industry where the big guys demanded regulation
Rahm Emanuel over the weekend asserted that it was historic — unprecedented — that the CEOs of the biggest artificial intelligence companies want federal regulation of AI. I've served in two White Houses and in Congressional…
Teva Pharmaceutical Industries Limited (TEVA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 8:30 AM EDT Richard Francis - President, CEO & Director Eric Hughes - Executive VP of Global R&D and Chief Medical Officer…
Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Wells Fargo upgraded Ulta Beauty (ULTA) to Equal Weight from…
Futures Drop As Yields, Oil Prices Keep Rising
Futures are lower - but well off session lows thanks to some well-time oil sell orders just before US traders walked in to work - as bond yields continue to make new highs, with both Nasdaq and Russell lagging the S&P which feels like more…
Hims & Hers: Pivot To Branded Distribution Is Eating The Margins Alive (NYSE:HIMS)
Hims & Hers has shifted to a branded pharmaceutical distribution model, compressing gross margins from 76% to 64% in one year. Despite 38% revenue growth in Q2, adjusted EBITDA declined 27% YoY, and free cash flow turned negative $68M, signaling…
Harbor Health Care ETF Q2 2026 Commentary (NYSEARCA:MEDI)
Health Care sentiment shifted meaningfully during the second quarter of 2026. During the second quarter, the Harbor Health Care ETF (“ETF”) returned 15.30%. Biotechnology was the largest contributor to relative performance during the…
China says ready to address Indian economic and trade concerns
China has said it is ready to expand trade and economic cooperation with India and address each other's concerns following recent high-level talks in New Delhi. ”China stands ready to work with India to implement the important consensus…
Swiss parliament tightens rules against fur abusers
Inside Geneva: gender champions speak out Read more: Inside Geneva: gender champions speak out How will layoffs at WHO impact the fight against air pollution? Read more: How will layoffs at WHO impact the fight against air pollution? Switzerland…
Eleva separates Bryotechnology platform and clinical-stage Factor H biotherapeutic into independent companies
Eleva Biologics will seek strategic partnerships for development and manufacturing of first-in-class and previously inaccessible biologics discovered with the Bryotechnology platform One04 Therapeutics will focus on progressing its wholly owned…
Receive a Daily briefing on Pharma Industry News
Get Started